Comparing Initial Glaucoma Treatment: Medication vs Surgery

The Collaborative Initial Glaucoma Treatment Study (CIGTS) is a research project focused on finding the best way to manage newly diagnosed open-angle glaucoma (OAG). Glaucoma is a condition that damages the eye's optic nerve, often due to high pressure inside the eye. Traditionally, eye drops are used to treat this condition. However, recent studies suggest that immediate surgery might be more effective. This study is important because it aims to improve the care and quality of life for people with OAG by determining which treatment approach works best. In this study, participants with newly diagnosed OAG are assigned to one of two treatment groups. One group receives a series of eye drop medications, starting with a single agent, usually a beta blocker. If the eye drops don't control the pressure inside the eye or if the patient's vision worsens, additional treatments are used, including argon laser trabeculoplasty and, if necessary, surgery. The other group undergoes immediate surgery, called trabeculectomy. If this surgery fails, they receive argon laser trabeculectomy, followed by medication if needed. Patients are assigned to these groups by chance, and if both eyes are eligible for treatment, they receive the same treatment. Throughout the study, participants visit the Clinical Centers for regular check-ups to evaluate their vision, eye pressure, and overall eye health. They also complete interviews over the phone to assess their health-related quality of life.